ArticleHemaSphere2025

Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conference.

Lucia de Franceschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.